Quantzig, a global data analytics and advisory firm that delivers actionable analytics solutions to resolve complex business problems, has announced the completion of its recent article that examines the role of artificial intelligence in pharmacovigilance.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200623005340/en/
The article also offers comprehensive insights on:
- The benefits of artificial intelligence in pharmacovigilance
- The role of artificial intelligence in pharmacovigilance and automation
Artificial intelligence in pharmacovigilance enables automation by leveraging artificial intelligence and machine learning. Request a FREE proposal for personalized recommendations.
Emphasis on drug safety is the key factor for the rising demand for pharmacovigilance solutions. With the focus on drug safety regulations on improving the drug quality more and more, pharmaceutical industry players are now depending on pharmacovigilance solutions. However, at times, it gets difficult to access huge amounts of patient data, which becomes a major pain point for the companies in the pharmaceutical industry to execute a holistic digital vigilance on the data that is generated. By deploying data mining and taking EHRs into consideration, artificial intelligence in pharmacovigilance successfully provides improved healthcare assistance.
Speak to our experts to learn how our artificial intelligence in pharmacovigilance can support activities that require medical expertise and analytical skills.
According to Quantzig’s artificial intelligence experts, “Artificial intelligence in pharmacovigilance aims to promote and protect the health and well-being of patients and other healthcare consumers.”
Role of Artificial Intelligence in Pharmacovigilance
1: Improve drug safety
2: Reliable monitoring
3: Increase scalability
Application of advanced analytics and artificial intelligence in pharmacovigilance helps in the clustering of data. Book a FREE Demo for expert insights on our advanced analytics solutions specially curated for the pharmaceutical industry.
Artificial intelligence in pharmacovigilance helps in protecting patient privacy, thus helping in adhering to government policies. Regulatory compliance has always been a pain point for the pharmaceutical industry. With every geographic location, the regulatory compliances change, thus pharma companies invest almost half of their resources in following regulations rather can solely educating themselves in drug development and discovery. The adaptation of artificial intelligence in pharmacovigilance helps companies by providing a reliable monitoring solution.
Read the complete article for detailed insights on the role of artificial intelligence in pharmacovigilance: https://bit.ly/3fYpp8T
Quantzig is a global analytics and advisory firm with offices in the US, UK, Canada, China, and India. For more than 15 years, we have assisted our clients across the globe with end-to-end data modeling capabilities to leverage analytics for prudent decision-making. Today, our firm consists of 120+ clients, including 55 Fortune 500 companies. For more information on our engagement policies and pricing plans, visit: https://www.quantzig.com/request-for-proposal.